Expression of the C-C chemokine MIP-3 alpha/CCL20 in human epidermis with impaired permeability barrier function
about
sameAs
Calcium triggers beta-defensin (hBD-2 and hBD-3) and chemokine macrophage inflammatory protein-3 alpha (MIP-3alpha/CCL20) expression in monolayers of activated human keratinocytesRegulation of the psoriatic chemokine CCL20 by E3 ligases Trim32 and Piasy in keratinocytesThe innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1.Human papillomavirus type 8 interferes with a novel C/EBPβ-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration.Decreased levels of circulating IL17-producing CD161+CCR6+ T cells are associated with graft-versus-host disease after allogeneic stem cell transplantation.Bioassay-guided evaluation of wound healing effect of fatty acids-incorporated collagen-based films.Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis.Langerhans cells - dendritic cells of the epidermis.Exodus-1 (CCL20): evidence for the participation of this chemokine in spontaneous labor at term, preterm labor, and intrauterine infection.Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosisPsoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins.CCR6 as a possible therapeutic target in psoriasis.Upregulation of chemokine (C-C motif) ligand 20 in adult epidermal keratinocytes in direct current electric fields.Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways.CCR6 is required for IL-23-induced psoriasis-like inflammation in mice.CCL20/MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tractThe human cutaneous chemokine system.Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses.CCL20 production is induced in human dental pulp upon stimulation by Streptococcus mutans and proinflammatory cytokines.Induction of cytokine (interleukin-1alpha and tumor necrosis factor-alpha) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure.Novel therapeutic targets along the Th17 pathway.To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis.Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression.Langerhans cells are critical in the development of atopic dermatitis-like inflammation and symptoms in mice.Human αβ and γδ T Cells in Skin Immunity and Disease.Nanoparticle-encapsulated baicalein markedly modulates pro-inflammatory response in gingival epithelial cellsTargeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers
P2860
Q28237916-37A8DD47-4345-46EB-ACF4-254AA146F651Q28511472-A6D16FBA-4813-4018-BC58-6DE0420D7775Q33769457-C828B079-B03D-4786-B8B2-CB846DB2DFA3Q34387292-FEB5EF1A-59E5-4A01-AE6C-DDFFA54A1262Q34506636-C479B30F-D091-47EE-BBF9-1EDBBA29D033Q34736670-22342C09-7493-49A0-ABE8-1BDC06492A5EQ34797596-ED807BF6-82EA-4AA5-B50E-E6EACB299B80Q35219303-7DF2D7FD-9A14-460D-9C85-25F8B8A76250Q35238598-683350D7-4605-421B-B51E-5BF5C08D6E04Q35555901-D36A6777-3424-45A3-9801-FF9F8940FA93Q35998473-F3945244-483E-48B4-BE10-4CD4D88F1ADFQ36980670-E86114BA-E6FF-4DE8-B9AD-B83EFA44B507Q37091305-DEC2A1CF-B329-4152-9FB0-CBBF4F12CED2Q37114379-801783D2-EDC4-4B71-BF49-62A94B827B3FQ37286597-5B94131C-DB54-495D-ACB9-B82E5F8A07D5Q37334297-22AE86EF-5041-4E91-855B-804DFF3EF6ECQ38008335-FE9BD0B9-DF6E-4084-A2F2-8B46DDCFE615Q38613574-D44D4D0F-7AE8-4E45-A3CD-3184347167FEQ39968006-DF602407-E323-4C84-858E-311898015D5AQ45243628-F2BECE7A-E16E-4A6D-8E37-876E8CEA7408Q46089932-BBD97F16-9EBB-446C-A34D-6811D929CEB4Q47859915-896063C6-3B99-4EAC-8BD2-09D06A97B358Q51040346-BFE0D3AC-9B10-4491-A822-0A99B3E5FFEBQ54476971-08194A57-43C5-4EB1-897A-C672BC027A1CQ55265385-59BF7A46-45F9-47F2-9338-BD8DB6258F8FQ58337851-E7958E2B-B264-4BCC-87F2-FA59464B1CF2Q58694964-909C5E78-51A9-452C-B998-456E8741AF62
P2860
Expression of the C-C chemokine MIP-3 alpha/CCL20 in human epidermis with impaired permeability barrier function
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Expression of the C-C chemokin ...... permeability barrier function
@ast
Expression of the C-C chemokin ...... permeability barrier function
@en
Expression of the C-C chemokin ...... permeability barrier function
@nl
type
label
Expression of the C-C chemokin ...... permeability barrier function
@ast
Expression of the C-C chemokin ...... permeability barrier function
@en
Expression of the C-C chemokin ...... permeability barrier function
@nl
prefLabel
Expression of the C-C chemokin ...... permeability barrier function
@ast
Expression of the C-C chemokin ...... permeability barrier function
@en
Expression of the C-C chemokin ...... permeability barrier function
@nl
P2093
P2860
P1476
Expression of the C-C chemokin ...... permeability barrier function
@en
P2093
A Grassegger
P2860
P304
P356
10.1034/J.1600-0625.2002.110205.X
P407
P577
2002-04-01T00:00:00Z